| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACAD10
|
acyl-CoA dehydrogenase family, member 10
|
|
ACAD11
|
acyl-CoA dehydrogenase family, member 11
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACOT11
|
acyl-CoA thioesterase 11
|
|
ACP2
|
acid phosphatase 2, lysosomal
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AEBP1
|
AE binding protein 1
|
|
AFP
|
alpha-fetoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARL8A
|
ADP-ribosylation factor-like 8A
|
|
ATAT1
|
alpha tubulin acetyltransferase 1
|
|
ATP13A2
|
ATPase type 13A2
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLOC1S2
|
biogenesis of lysosomal organelles complex-1, subunit 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CAT
|
catalase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD200
|
CD200 molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD34
|
CD34 molecule
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD86
|
CD86 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDNF
|
cerebral dopamine neurotrophic factor
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLEC4G
|
C-type lectin domain family 4, member G
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CRADD
|
CASP2 and RIPK1 domain containing adaptor with death domain
|
|
CRAT
|
carnitine O-acetyltransferase
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTGF
|
connective tissue growth factor
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DLX5
|
distal-less homeobox 5
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
EDN1
|
endothelin 1
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ETFA
|
electron-transfer-flavoprotein, alpha polypeptide
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FBLN1
|
fibulin 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGF16
|
fibroblast growth factor 16
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMOD
|
fibromodulin
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXL2
|
forkhead box L2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAST
|
gastrin
|
|
GATA6
|
GATA binding protein 6
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GRK4
|
G protein-coupled receptor kinase 4
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HMGCL
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HP
|
haptoglobin
|
|
HRASLS
|
HRAS-like suppressor
|
|
HRH3
|
histamine receptor H3
|
|
HRH4
|
histamine receptor H4
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ILK
|
integrin-linked kinase
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
ITSN1
|
intersectin 1 (SH3 domain protein)
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JMJD1C
|
jumonji domain containing 1C
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KATNA1
|
katanin p60 (ATPase containing) subunit A 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM8
|
lysine (K)-specific demethylase 8
|
|
KDR
|
kinase insert domain receptor
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMO
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT14
|
keratin 14, type I
|
|
KRT16
|
keratin 16, type I
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LCN2
|
lipocalin 2
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LPL
|
lipoprotein lipase
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MIR205
|
microRNA 205
|
|
MIR221
|
microRNA 221
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSRA
|
methionine sulfoxide reductase A
|
|
MSX2
|
msh homeobox 2
|
|
MTBP
|
MDM2 binding protein
|
|
MTM1
|
myotubularin 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NLRP10
|
NLR family, pyrin domain containing 10
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOX4
|
NADPH oxidase 4
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
OBP2A
|
odorant binding protein 2A
|
|
ORC2
|
origin recognition complex, subunit 2
|
|
OXTR
|
oxytocin receptor
|
|
PACRG
|
PARK2 co-regulated
|
|
PADI6
|
peptidyl arginine deiminase, type VI
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA6
|
protein disulfide isomerase family A, member 6
|
|
PDPN
|
podoplanin
|
|
PDYN
|
prodynorphin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEX19
|
peroxisomal biogenesis factor 19
|
|
PF4
|
platelet factor 4
|
|
PF4V1
|
platelet factor 4 variant 1
|
|
PGR
|
progesterone receptor
|
|
PI16
|
peptidase inhibitor 16
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PNP
|
purine nucleoside phosphorylase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLD2
|
polymerase (DNA directed), delta 2, accessory subunit
|
|
POLD3
|
polymerase (DNA-directed), delta 3, accessory subunit
|
|
PON1
|
paraoxonase 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PROK2
|
prokineticin 2
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PSCA
|
prostate stem cell antigen
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRQ
|
protein tyrosine phosphatase, receptor type, Q
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RABL6
|
RAB, member RAS oncogene family-like 6
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELN
|
reelin
|
|
RHO
|
rhodopsin
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RLN3
|
relaxin 3
|
|
RTN1
|
reticulon 1
|
|
RXFP4
|
relaxin/insulin-like family peptide receptor 4
|
|
RXRG
|
retinoid X receptor, gamma
|
|
S100A7
|
S100 calcium binding protein A7
|
|
SAA1
|
serum amyloid A1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCOC
|
short coiled-coil protein
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SHH
|
sonic hedgehog
|
|
SIRT1
|
sirtuin 1
|
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNTG1
|
syntrophin, gamma 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SP7
|
Sp7 transcription factor
|
|
SPINK9
|
serine peptidase inhibitor, Kazal type 9
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTBN5
|
spectrin, beta, non-erythrocytic 5
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYN3
|
synapsin III
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBCE
|
tubulin folding cofactor E
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TH
|
tyrosine hydroxylase
|
|
TKTL1
|
transketolase-like 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIM22
|
tripartite motif containing 22
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSN
|
translin
|
|
TXNDC12
|
thioredoxin domain containing 12 (endoplasmic reticulum)
|
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
|
TYMP
|
thymidine phosphorylase
|
|
UMPS
|
uridine monophosphate synthetase
|
|
USH1G
|
Usher syndrome 1G (autosomal recessive)
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS29
|
vacuolar protein sorting 29 homolog (S. cerevisiae)
|
|
WAC
|
WW domain containing adaptor with coiled-coil
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
XCR1
|
chemokine (C motif) receptor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YBX1
|
Y box binding protein 1
|
|
YTHDC1
|
YTH domain containing 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZDHHC17
|
zinc finger, DHHC-type containing 17
|
